(Q74665094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Biological activity of GLP-1-analogues with N-terminal modifications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

E G Siegel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

B Gallwitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G Scharf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Mentlein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Morys-Wortmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

U R Fölsch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J Schrezenmeir

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K Drescher

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W E Schmidt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

93-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Structure/activity characterization of glucagon-like peptide-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Proteins of the kidney microvillar membrane. The amphipathic form of dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Methods for the investigation of neuropeptide catabolism and stability in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Regulation of immunoreactive-insulin release from a rat cell line (RINm5F)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Determination of blood glucose using 4-amino phenazone as oxygen acceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2898%2900155-4

7 January 2021

10.1016/S0167-0115(98)00155-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10100921%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference